13D/13G Filings - ARCH Venture Fund VII L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
5:11 pm
Purchase		 2024-09-30 13G 908 Devices Inc.
MASS		 ARCH Venture Fund VII L.P. 5,782,548
16.600%		 26,106increase
(+0.45%)		 Filing
History
2024-02-09
5:34 pm
Purchase		 2023-12-31 13G 908 Devices Inc.
MASS		 ARCH Venture Fund VII L.P. 5,756,442
17.800%		 11,843increase
(+0.21%)		 Filing
History
2023-02-13
4:06 pm
Purchase		 2022-12-31 13G 908 Devices Inc.
MASS		 ARCH Venture Fund VII L.P. 5,744,599
18.100%		 12,313increase
(+0.21%)		 Filing
History
2022-02-11
4:55 pm
Purchase		 2021-12-31 13G Unity Biotechnology, Inc.
UBX		 ARCH Venture Fund VII L.P. 1,013,886
17.500%		 3,856increase
(+0.38%)		 Filing
History
2022-02-08
3:03 pm
Purchase		 2021-12-31 13G 908 Devices Inc.
MASS		 ARCH Venture Fund VII L.P. 5,732,286
18.500%		 6,440increase
(+0.11%)		 Filing
History
2021-02-04
2:03 pm
Purchase		 2020-12-31 13G 908 Devices Inc.
MASS		 ARCH Venture Fund VII L.P. 5,725,846
21.100%		 5,725,846increase
(New Position)		 Filing
History
2021-02-02
5:03 pm
Purchase		 2020-12-31 13G Unity Biotechnology, Inc.
UBX		 ARCH Venture Fund VII L.P. 1,010,030
19.100%		 3,856increase
(+0.38%)		 Filing
History
2021-02-02
5:02 pm
Sale		 2020-12-31 13G Twist Bioscience Corporation
TWST		 ARCH Venture Fund VII L.P. 0
0.000%		 -3,367,158decrease
(Position Closed)		 Filing
History
2021-02-02
5:02 pm
Sale		 2020-12-31 13G Syros Pharmaceuticals, Inc.
SYRS		 ARCH Venture Fund VII L.P. 0
0.000%		 -334,177decrease
(Position Closed)		 Filing
History